等待开盘 04-02 09:30:00 美东时间
0.000
0.00%
Culp President, CEO Robert George Culp IV buys USD 0 million Culp shares Culp President and CEO Robert George Culp IV reported a purchase of 3,179 common shares at $2.90. Directly held common shares increased to 126,317. Indirect holdings included 1,740 common shares held in trust for his daughter.
04-01 10:00
LIVE MARKETS-Bounce day? Stocks start the week with modest gains U.S. stock indexes modestly green; Dow up most Energy leads S&P sector gainers; Industrials weakest group Euro STOXX 600 index up ~0.5% Dollar up; US crude up >2%; gold gains; bitcoin advances >1% US 10-Year Treasury yield falls to ~4.
03-30 22:05
BUZZ-Law firm probes short-seller claims at ADMA Biologics; shares up ** Shares of biotech firm ADMA Biologics ADMA.O rise 2% to $9.40 premarket ** Securities law firm Bleichmar Fonti & Auld says it is investigating the drugmaker for potential securities law violations ** Probe follows a March 24 re
03-30 18:20
Culpeo Minerals Limited ( ($AU:CPO) ) has issued an announcement. Culpeo Minera...
03-30 08:17
Shares of Vor Biopharma Inc. (NASDAQ: VOR) are trading higher Friday after pricing a $14.05 private placement of 5.4 million shares.
03-27 23:15
U.S. stocks lower, Nasdaq falls 1%. Oxford Industries up 11.2% on strong earnings, raised dividend. Other gains: AGX 35.5%, MSC 24.5%, ADMA 13%, SGML 12.2%, KOD 10.5%, TBN 9.9%, METC 8.8%, U 8.3%, MEOH 7.7%, VOR 6.8%, Kopin Corp.
03-27 22:29
ADMA Biologics (ADMA) rose 15% after refuting claims from a Culper Research short report. "ADMA believes that by providing, on a non-recurring basis, additional details concerning the Company’s immun...
03-27 21:44
ADMA Biologics, Inc. (NASDAQ: ADMA) shares are tumbling on Thursday as traders lean into risk-off positioning and punish weaker charts in a down tape. The Nasdaq is down 0.91% while the S&P 500 has shed 0.57%, and ADMA is moving with the broader market decline but with heavier downside pressure than the major indices.
03-27 00:34
ADMA Biologics shares drop after Culper Research short report alleges financial misreporting; company pushes back.
03-26 01:22
BUZZ-ADMA Biologics rises after rejecting short-seller report ** Shares of biotech firm ADMA Biologics ADMA.O rise about 3% to $11.63 premarket ** ADMA rejects a negative report by Culper Research, which has a short position in the stock ** Culper on March 24 accused the company of inflating its sal
03-25 18:43